2RFJ
Crystal structure of the bromo domain 1 in human bromodomain containing protein, testis specific (BRDT)
Summary for 2RFJ
Entry DOI | 10.2210/pdb2rfj/pdb |
Descriptor | Bromodomain testis-specific protein (2 entities in total) |
Functional Keywords | brdt, bromodomain containing protein testis specific, structural genomics consortium, sgc, nucleus, transcription, transcription regulation, transcription regulator |
Biological source | Homo sapiens (human) |
Cellular location | Nucleus (Probable): Q58F21 |
Total number of polymer chains | 3 |
Total formula weight | 42499.28 |
Authors | Filippakopoulos, P.,Salah, E.,Savitsky, P.,Keates, T.,Parizotto, E.,Elkins, J.,Pike, A.C.W.,Ugochukwu, E.,von Delft, F.,Arrowsmith, C.H.,Edwards, A.M.,Weigelt, J.,Sundstrom, M.,Knapp, S.,Structural Genomics Consortium (SGC) (deposition date: 2007-09-30, release date: 2007-10-23, Last modification date: 2023-08-30) |
Primary citation | Filippakopoulos, P.,Picaud, S.,Mangos, M.,Keates, T.,Lambert, J.P.,Barsyte-Lovejoy, D.,Felletar, I.,Volkmer, R.,Muller, S.,Pawson, T.,Gingras, A.C.,Arrowsmith, C.H.,Knapp, S. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell(Cambridge,Mass.), 149:214-231, 2012 Cited by PubMed Abstract: Bromodomains (BRDs) are protein interaction modules that specifically recognize ε-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks. The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity. Here, we present 29 high-resolution crystal structures, covering all BRD families. Comprehensive crossfamily structural analysis identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition. Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences. We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-containing peptides by BRD4. These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family. PubMed: 22464331DOI: 10.1016/j.cell.2012.02.013 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.05 Å) |
Structure validation
Download full validation report